Rafael Holdings
Rafael Holdings Logo
About Rafael Holdings
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies and commercial real estate assets in the United States and Israel. The company operates in healthcare, infusion technology, and real estate segments. Its portfolio includes the development and commercialization of novel cancer therapeutics, such as CPI-613 (devimistat), Promitil, and other oncology-focused drug candidates, as well as real estate development and management. Incorporated in 2017 and headquartered in Newark, New Jersey, Rafael Holdings manages a diversified set of assets across the healthcare and real estate sectors.
Address
520 Broad Street,
Newark, 07102
United States
Year founded
2017
Number of employees
0-100
Sector
Real Estate
Industry Group
Real Estate Management & Development
Industry
Real Estate Management & Development
Subindustry
Diversified Real Estate Activities
Report inaccurate data
Request an update to help us keep the brand up-to-date.
